8	23	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 14), 'text':'Stimulation of the TCR initiates activation of cytoplasmic protein tyrosine kinases ( PTKs ) 1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 15), 'end':(0, 19), 'text':'that trigger downstream signaling pathways'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 20), 'end':(0, 26), 'text':'including calcium- and Ras- dependent events ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 27), 'end':(0, 32), 'text':'which ultimately converge upon the nucleus'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 33), 'end':(0, 38), 'text':'to stimulate the transcription of genes'}, {'start':(0, 39), 'end':(0, 51), 'text':'required for proliferation and effector functions of T cells ( - ) .'}]}]}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 2), 'text':'Phospholipase Cgamma1 ,'}, {'start':(1, 3), 'end':(1, 11), 'text':'recruited to the plasma membrane after PTK activation ,'}]}, {'start':(1, 12), 'end':(1, 26), 'text':'is thought to introduce the calcium dependent pathway into the TCR mediated signaling events .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 19), 'text':'On the other hand , the pathway for Ras activation after PTK activation in T cells is still controversial .'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 4), 'text':'Grb2 , an adaptor protein'}, {'start':(3, 5), 'end':(3, 9), 'text':'containing an SH3-SH2-SH3 motif ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 10), 'end':(3, 31), 'text':'forms a complex with Sos , a guanine nucleotide exchange factor , via its NH 2 -terminal SH3 domain after TCR ligation'}, {'start':(3, 32), 'end':(3, 35), 'text':'( - ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 17), 'text':'Hence , the Grb2 and Sos complex is thought to contribute to Ras activation in T cells ,'}, {'start':(4, 18), 'end':(4, 28), 'text':'although there has been no empirical evidence for this notion .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 14), 'text':'The COOH-terminal SH3 domain of Grb2 has been shown to bind to the SH2 domain'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 15), 'end':(5, 31), 'text':'containing leukocyte protein of 76 kD ( SLP-76 ) , a hematopoietic cell specific adaptor protein ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 32), 'end':(5, 39), 'text':'which is tyrosine phosphorylated rapidly after TCR stimulation'}, {'start':(5, 40), 'end':(5, 43), 'text':'( - ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 0), 'text':'Mice'}, {'start':(6, 1), 'end':(6, 29), 'text':'targeted for SLP-76 gene engendered defects of double positive T cells in the thymus and of peripheral T cells as a consequence of impaired pre-TCR signaling ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 5), 'text':'Furthermore , Jurkat subline J14 cells'}, {'start':(7, 6), 'end':(7, 24), 'text':'lacking expression of SLP-76 exhibited defects of both the calcium- and Ras dependent pathways in TCR mediated signaling .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 14), 'text':'The defect of the calcium dependent pathway in this system is ascribed to the fact'}, {'start':(8, 15), 'end':(8, 31), 'text':'that tyrosine phosphorylation and activation of phospholipase Cgamma1 are significantly suppressed in J14 cells ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 12), 'text':'Although the precise function of SLP-76 in Ras activation is still obscure ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 13), 'end':(9, 16), 'text':'it is of interest'}, {'start':(9, 17), 'end':(9, 41), 'text':'that deletion of the Grb2 binding site of SLP-76 eliminates the ability of SLP-76 to increase IL-2 promoter activity upon stimulation with the TCR .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 18), 'text':'In addition , SLP-76 also binds to Vav , a member of the guanine nucleotide exchange factor family ,'}, {'start':(10, 19), 'end':(10, 48), 'text':'and cotransfection with SLP-76 and Vav into Jurkat cells induced a synergistic increase of nuclear factor of activated T cell ( NF-AT ) activation upon TCR stimulation ( ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 2), 'text':'These observations suggest'}, {'start':(11, 3), 'end':(11, 12), 'text':'that SLP-76 is an indispensable mediator of TCR signaling .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 16), 'text':'On the other hand , the SH2 domain of Grb2 has been shown to bind to linker'}, {'start':(12, 17), 'end':(12, 40), 'text':'for activation of T cells ( LAT ) , a ZAP-70 tyrosine kinase substrate , upon TCR stimulation , and the LAT mutant ,'}]}, {'start':(12, 41), 'end':(12, 49), 'text':'lacking an interaction site for the SH2 domain ,'}]}, {'start':(12, 50), 'end':(12, 61), 'text':'has a dominant negative effect on TCR stimulated signaling ( ) .'}]}, {'start':(13, 0), 'end':(13, 17), 'text':'Hence Grb2 , an adaptor protein , has been considered to be implicated in TCR mediated signaling .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 3), 'text':'We here provide evidence'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 4), 'end':(14, 10), 'text':'that a new Grb2 family member ,'}, {'start':(14, 11), 'end':(14, 13), 'text':'named Grf40 ,'}]}, {'start':(14, 14), 'end':(14, 31), 'text':'is involved in TCR mediated signaling through its more efficient interaction than Grb2 with SLP-76 and LAT .'}]}]}]}
0	1	{'start':(0, 0), 'end':(0, 19), 'text':'Grf40 , A Novel Grb2 Family Member , Is Involved in T Cell Signaling through Interaction with SLP-76 and LAT'}
23	70	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and Methods'}, {'start':(1, 0), 'end':(1, 4), 'text':'Cloning of the cDNA .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 15), 'text':'Grf40 cDNA fragments were isolated by a yeast two-hybrid screen of a human PHA-PBL cDNA library'}, {'start':(2, 16), 'end':(2, 19), 'text':'( Clontech ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 10), 'text':'The bait plasmid was constructed by insertion of a cDNA fragment'}, {'start':(3, 11), 'end':(3, 27), 'text':'encoding the full-length human AMSH protein ( our unpublished protocol ) in pAS2-1 ( Clontech ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 13), 'text':'The bait plasmid was transformed into the yeast strain CG1945 ( Clontech ) ,'}, {'start':(4, 14), 'end':(4, 23), 'text':'followed by transformation with the human PHA-PBL cDNA library .'}]}, {'start':(5, 0), 'end':(5, 22), 'text':'The transformed strains were selected on dropout plates ( Trp - , Leu - , His - ) with 5 mM 3-aminotriazole .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 10), 'text':'Positive colonies were subsequently tested for the expression of lacZ .'}, {'start':(7, 0), 'end':(7, 13), 'text':'One clone was determined to contain a homologous sequence to Grb2 ( ) .'}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 5), 'text':'To obtain the full-length cDNA ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 6), 'end':(8, 17), 'text':'the 800-bp fragment of the above clone was used as a probe'}, {'start':(8, 18), 'end':(8, 32), 'text':'for screening a lambdagt11 oligo ( dT ) - primed cDNA library of PHA-PBL .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 7), 'text':'The sequences of 10 clones were identical ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 8), 'end':(9, 16), 'text':'and two of them contained an open reading frame'}, {'start':(9, 17), 'end':(9, 22), 'text':'coding for 330 amino acids .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 0), 'end':(10, 2), 'text':'This sequence contains'}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 3), 'end':(10, 16), 'text':'an in-frame stop codon at 114 bp upstream of the first methionine codon ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 17), 'end':(10, 23), 'text':'and the sequence around the first methionine'}, {'start':(10, 24), 'end':(10, 34), 'text':'( nucleotides 193-195 ) matches the favorable Kozak consensus sequence .'}]}]}]}, {'start':(11, 0), 'end':(11, 8), 'text':'A full-length cDNA encoding Grf40 was thus isolated .'}]}]}]}]}, {'start':(12, 0), 'end':(12, 2), 'text':'Plasmid Construction .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 5), 'text':'Grf40 cDNA was generated by PCR'}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 6), 'end':(13, 14), 'text':'using the above full-length cDNA clone as a template'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 15), 'end':(13, 27), 'text':'and subcloned into Myc-Tag-pcDNA3 .1 ( + ) to generate the plasmid sequence'}, {'start':(13, 28), 'end':(13, 31), 'text':'( EQKLISEEDL ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 12), 'text':'pMycGrf40-dSH3N , pMycGrf40-dSH2 , pMycGrf40-dSH3C , and pMycGrf40-dSH3NC are Myc tagged Grf40 mutants'}, {'start':(14, 13), 'end':(14, 32), 'text':'deleted of the SH3 domain of the NH 2 terminus ( amino acid position Met 1 -Pro 56 ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 33), 'end':(14, 37), 'text':'deleted of the SH2 domain'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 38), 'end':(14, 55), 'text':'( amino acid position Lys 57 -Thr 149 ) , of the SH3 domain of the COOH terminus'}, {'start':(14, 56), 'end':(14, 65), 'text':'( amino acid position Ala 278 -Arg 330 ) ,'}]}, {'start':(14, 66), 'end':(14, 94), 'text':'and of the SH3 domains of the NH 2 and COOH termini ( amino acid positions Met 1 -Pro 56 and Ala 278 -Arg 330 ) , respectively .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 5), 'text':'pMycGrb2 and pMycGrb2-dSH2 are expression plasmids'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 6), 'end':(15, 14), 'text':'for the Myc tagged wild-type Grb2 and Grb2 mutant'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 15), 'end':(15, 19), 'text':'deleted of the SH2 domain'}, {'start':(15, 20), 'end':(15, 31), 'text':'( amino acid position Trp 60 -Glu 152 ) , respectively .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 5), 'text':'SLP-76 cDNA was generated by PCR'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 6), 'end':(16, 9), 'text':'and subcloned into pFLAG-CMV-2'}, {'start':(16, 10), 'end':(16, 14), 'text':'( Eastman Kodak Co. )'}]}]}, {'start':(16, 15), 'end':(16, 20), 'text':'to generate the plasmid pFlagSLP ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 21), 'end':(16, 28), 'text':'possessing an NH 2 -terminal Flag epitope tag'}, {'start':(16, 29), 'end':(16, 32), 'text':'( DYKDDDDK ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 16), 'text':'pFlagSLP-157-533 , pFlagSLP-217-533 , pFlagSLP-241-533 , and pFlagSLP-281-533 are expression plasmids for Flag tagged SLP 76 mutants'}, {'start':(17, 17), 'end':(17, 44), 'text':'deleted of amino acid positions Met 1 -Leu 156 , Met 1 -His 216 , Met 1 -Lys 240 , and Met 1 -Pro 280 , respectively .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 8), 'text':'pCX-SLP76 is an expression plasmid for the wild-type SLP-76'}, {'start':(18, 9), 'end':(18, 16), 'text':'cloned into the pCXN2 vector ( ) .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 3), 'text':'Luciferase reporter constructs were'}, {'start':(19, 4), 'end':(19, 6), 'text':'as follows :'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 7), 'end':(19, 28), 'text':'pNFATLuc was constructed by insertion of three tandem copies of the NF-AT binding region ( -286 to -249 of human IL-2 )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 29), 'end':(19, 43), 'text':'linked to the human IL-2 promoter ( -64 to +47 ) into the pGL3-basic vector'}, {'start':(19, 44), 'end':(19, 49), 'text':'( Promega ) ( ) ;'}]}]}]}, {'start':(19, 50), 'end':(19, 71), 'text':'pIL2Luc was constructed by insertion of the human IL-2 promoter ( -541 to +57 ) into the pGL3-basic vector ( ) .'}]}, {'start':(20, 0), 'end':(20, 8), 'text':'pENL is a beta-galactosidase expression plasmid ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 9), 'text':'All constructs were sequenced for verification with a DNA sequencer'}, {'start':(21, 10), 'end':(21, 13), 'text':'( model 377 ;'}]}, {'start':(21, 14), 'end':(21, 19), 'text':'Applied Biosystems , Inc. ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(22, 0), 'end':(22, 2), 'text':'Cell Culture .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(23, 0), 'end':(23, 12), 'text':'Cell lines used were human T cell lines , Jurkat and MOLT-4 ;'}, {'label':'joint', 'direction':'None', 'children':[{'start':(23, 13), 'end':(23, 24), 'text':'human B cell lines , Daudi , Raji , and Ramos ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 25), 'end':(23, 68), 'text':'a human monocytic cell line , THP-1 ; a human eosinophilic cell line , Eol-3 ; a human GM-CSF-responsive cell line , TF-1 ; a human lung fibroblastic cell line , WI-26 ; a human epithelial cell line , HeLa ; and an SV40'}, {'start':(23, 69), 'end':(23, 76), 'text':'transformed monkey kidney cell line , COS7 .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 6), 'text':'TF-1 was maintained in RPMI 1640 medium'}, {'start':(24, 7), 'end':(24, 15), 'text':'supplemented with 10 % FCS and recombinant GM-CSF .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 6), 'text':'WI-26 and COS7 were maintained in DME'}, {'start':(25, 7), 'end':(25, 12), 'text':'supplemented with 5 % FCS .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 7), 'text':'Other cell lines were maintained in RPMI 1640'}, {'start':(26, 8), 'end':(26, 13), 'text':'supplemented with 10 % FCS .'}]}]}]}]}]}, {'start':(27, 0), 'end':(27, 1), 'text':'Abs .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 8), 'text':'The following Abs were used in this study :'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 9), 'end':(28, 41), 'text':'anti-CD3epsilon mAb OKT3 ( American Type Culture Collection ) ; antiphosphotyrosine mAb 4G10 , anti-Myc polyclonal Ab and anti-LAT Ab ( Upstate Biotechnology ) ; antiphosphotyrosine mAb PY-20 ( ICN Biomedicals ) ;'}, {'start':(28, 42), 'end':(28, 58), 'text':'anti-Myc mAb ( 9E10 ) and anti-Grb2 Ab ( sc-255 ) ( Santa Cruz Biotechnology ) ;'}]}, {'start':(28, 59), 'end':(28, 68), 'text':'anti-Flag mAb ( M2 ; Eastman Kodak Co. ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 9), 'text':'Anti-Grf40 rabbit antiserum was prepared by immunization with a peptide'}, {'start':(29, 10), 'end':(29, 19), 'text':'( Val 174 -Pro 194 ) of human Grf40 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 9), 'text':'Anti-SLP-76 rabbit antiserum was prepared by immunization with a peptide'}, {'start':(30, 10), 'end':(30, 19), 'text':'( Gly 302 -Glu 321 ) of human SLP-76 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 13), 'text':'Anti-B19 human parvovirus mAb ( Par1 ) was used as a control mAb .'}, {'start':(32, 0), 'end':(32, 3), 'text':'Immunoprecipitation and Immunoblotting .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 5), 'text':'Immunoprecipitation and immunoblotting were carried out'}, {'start':(33, 6), 'end':(33, 11), 'text':'as described previously ( ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(34, 0), 'end':(34, 50), 'text':'In brief , cells were lysed with a cell extraction buffer ( 1 % NP-40 , 20 mM Tris-HCl [ pH 7.5 ] , 150 mM NaCl , 1 mM EDTA , 1 mM Na 3 VO 4 , 2 mM PMSF , and 20 mug and ml aprotinin ) ,'}, {'start':(34, 51), 'end':(34, 59), 'text':'and immunoprecipitated with the indicated Abs or antisera .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(35, 0), 'end':(35, 5), 'text':'The immunoprecipitates were separated by SDS-PAGE'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 6), 'end':(35, 12), 'text':'and then transferred to polyvinylidene difluoride filters'}, {'start':(35, 13), 'end':(35, 16), 'text':'( Millipore ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 0), 'end':(36, 21), 'text':'After incubation in PBS containing 2 % BSA and 0.1 % Tween 20 , the filters were probed with the indicated Abs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 22), 'end':(36, 28), 'text':'and visualized using the ECL detection system'}, {'start':(36, 29), 'end':(36, 34), 'text':'( Amersham Pharmacia Biotech ) .'}]}]}]}]}]}]}, {'start':(37, 0), 'end':(37, 2), 'text':'Northern Blotting .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 4), 'text':'Northern blot analyses were performed'}, {'start':(38, 5), 'end':(38, 10), 'text':'as described previously ( ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 9), 'text':'In brief , a Multiple Tissue Northern blot containing poly'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 10), 'end':(39, 15), 'text':'( A ) + RNA preparations'}, {'start':(39, 16), 'end':(39, 26), 'text':'derived from various human tissues was purchased ( Clontech ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 0), 'end':(40, 11), 'text':'They were probed with radiolabeled cDNA fragments of Grf40 and beta-actin .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 18), 'text':'Signals were analyzed with a Bio-Image Analyzer , BAS 1500 ( Fuji Film and Photo , Inc. ) .'}, {'start':(42, 0), 'end':(42, 5), 'text':'Transient Transfections and Luciferase Assay .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(43, 0), 'end':(43, 44), 'text':'COS7 cells were electroporated with the indicated plasmids in OPTI-MEM I ( GIBCO BRL ) at a density of 6 x 10 6 cells and 700 mul and cuvette with a gene pulser ( Bio-Rad Laboratories ) set at 1,000 V and 200 muF ,'}, {'start':(43, 45), 'end':(43, 58), 'text':'and then subjected to a Western blot assay 48 h after the transfection .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 54), 'text':'For luciferase assays , Jurkat cells were electroporated with 2.5 mug of pENL and the indicated dose of pIL2Luc or pNFATLuc , along with expression plasmids for SLP-76 , and Grf40 or Grb2 in OPTI-MEM I at a density of 5 x 10 6 cells and 400 mul at 200 V and 950 muF .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(45, 0), 'end':(45, 9), 'text':'The cells were cultured at 37degreesC for 24 h ,'}, {'start':(45, 10), 'end':(45, 36), 'text':'and then stimulated for 8 h with 10 mug and ml OKT3 plus 50 ng and ml PMA or with 10 mug and ml OKT3 alone .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 11), 'text':'The cells were then lysed in 300 mul of PicaGene ReporterLysis Buffer'}, {'start':(46, 12), 'end':(46, 15), 'text':'( Toyo Ink )'}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(46, 16), 'end':(46, 22), 'text':'and assayed for luciferase and beta-galactosidase activities'}, {'start':(46, 23), 'end':(46, 28), 'text':'as described previously ( ) .'}]}]}]}]}]}]}
1	8	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 8), 'text':'We molecularly cloned a new Grb2 family member ,'}, {'start':(0, 9), 'end':(0, 11), 'text':'named Grf40 ,'}]}, {'start':(0, 12), 'end':(0, 17), 'text':'containing the common SH3-SH2-SH3 motif .'}]}, {'start':(1, 0), 'end':(1, 12), 'text':'Expression of Grf40 is predominant in hematopoietic cells , particularly T cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 5), 'text':'Grf40 binds to the SH2 domain'}, {'start':(2, 6), 'end':(2, 23), 'text':'containing leukocyte protein of 76 kD ( SLP-76 ) via its SH3 domain more tightly than Grb2 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 19), 'text':'Incidentally , Grf40 binds to linker for activation of T cells ( LAT ) possibly via its SH2 domain .'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 13), 'text':'Overexpression of wild-type Grf40 in Jurkat cells induced a significant increase of SLP-76-dependent interleukin'}, {'start':(4, 14), 'end':(4, 38), 'text':'( IL ) -2 promoter and nuclear factor of activated T cell ( NF-AT ) activation upon T cell receptor ( TCR ) stimulation ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 39), 'end':(4, 42), 'text':'whereas the COOH-terminal SH3'}, {'start':(4, 43), 'end':(4, 54), 'text':'deleted Grf40 mutant lacked any recognizable increase in IL-2 promoter activity .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 3), 'text':'Furthermore , the SH2'}, {'start':(5, 4), 'end':(5, 16), 'text':'deleted Grf40 mutant led to a marked inhibition of these regulatory activities ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 17), 'end':(5, 28), 'text':'the effect of which is apparently stronger than that of the SH2'}, {'start':(5, 29), 'end':(5, 32), 'text':'deleted Grb2 mutant .'}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 2), 'text':'Our data suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 3), 'end':(6, 8), 'text':'that Grf40 is an adaptor molecule'}, {'start':(6, 9), 'end':(6, 25), 'text':'involved in TCR mediated signaling through a more efficient interaction than Grb2 with SLP-76 and LAT .'}]}]}]}
153	154	{'start':(0, 0), 'end':(0, 2), 'text':'Figures and Tables'}
70	153	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'topic-change', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Results and Discussion'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 10), 'text':'We previously reported a signal transducing adaptor molecule , STAM ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 11), 'end':(1, 22), 'text':'which is associated with Janus kinase ( Jak ) 2 and Jak3'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 23), 'end':(1, 28), 'text':'and is involved in signal transduction'}, {'start':(1, 29), 'end':(1, 36), 'text':'mediated by IL-2 and GM-CSF ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 7), 'text':'We have also recently cloned a cDNA clone'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 8), 'end':(2, 12), 'text':'encoding a novel molecule ,'}, {'start':(2, 13), 'end':(2, 15), 'text':'named AMSH ,'}]}, {'start':(2, 16), 'end':(2, 25), 'text':'which binds to STAM ( our unpublished results ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 7), 'text':'To address the functional significance of AMSH ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 8), 'end':(3, 12), 'text':'we attempted to identify molecules'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 13), 'end':(3, 15), 'text':'associated with AMSH'}, {'start':(3, 16), 'end':(3, 22), 'text':'using the yeast two-hybrid assay system .'}]}]}]}, {'start':(4, 0), 'end':(4, 12), 'text':'One full-length cDNA clone was isolated from a human PHA-PBL cDNA library .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 21), 'text':'The cDNA clone encodes a molecule homologous to Grb2 , named Grf40 ( for Grb2 family member of 40 kD ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 12), 'text':'The nucleotide sequence of the Grf40 gene has been deposited with GenBank ,'}, {'start':(6, 13), 'end':(6, 21), 'text':'and is available from EMBL/GenBank/DDBJ under accession no .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 1), 'text':'AF042380 .'}, {'start':(8, 0), 'end':(8, 13), 'text':'The deduced amino acid sequence of Grf40 consists of 330 amino acid residues .'}]}]}, {'start':(9, 0), 'end':(9, 18), 'text':'The schematic structure of Grf40 was compared with Grb2 ( ) and Grap , another Grb2 family member .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 24), 'text':'The NH 2 - and COOH-terminal SH3 domains and an intermediate SH2 domain of Grf40 are highly homologous to those of Grb2 and Grap ,'}, {'start':(10, 25), 'end':(10, 38), 'text':'while a unique insert region ( amino acid position Arg 156 -Arg 277 )'}]}, {'start':(10, 39), 'end':(10, 40), 'text':'containing proline'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 41), 'end':(10, 48), 'text':'/ glutamine rich sequences was seen in Grf40'}, {'start':(10, 49), 'end':(10, 54), 'text':'but not Grb2 and Grap .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 2), 'text':'These results indicate'}, {'start':(11, 3), 'end':(11, 13), 'text':'that Grf40 is a new member of the Grb2 family .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 9), 'text':'Various human cell lines were examined for expression of Grf40'}, {'start':(12, 10), 'end':(12, 15), 'text':'by immunoblotting with anti-Grf40 Ab .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 18), 'text':'Two T cell lines , MOLT-4 and Jurkat , were strongly positive for expression of the 40-kD Grf40 ,'}, {'start':(13, 19), 'end':(13, 32), 'text':'and two B cell lines , Daudi and Raji , were weakly positive ,'}]}, {'start':(13, 33), 'end':(13, 38), 'text':'but the other cell lines ,'}]}, {'start':(13, 39), 'end':(13, 59), 'text':'including a B cell line ( Ramos ) , myeloid cell lines ( THP-1 , TF-1 , and Eol-3 ) ,'}]}, {'start':(13, 60), 'end':(13, 76), 'text':'and the nonhematopoietic cell lines ( HeLa and WI-26 ) were all negative for this expression .'}]}]}, {'start':(14, 0), 'end':(14, 16), 'text':'In contrast to Grf40 , appreciable expression of Grb2 was seen in all the cell lines .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 44), 'text':'Northern blot analyses on various human cell lines and tissues showed two Grf40 specific transcripts at 3.5 and 1.5 kb in Jurkat , MOLT-4 , three myeloid cell lines ( KU812 , K562 , and M-TAT ) and PHA-PBL ( data not shown ) ,'}, {'start':(15, 45), 'end':(15, 72), 'text':'and in human immunotissues such as thymus , spleen , small intestine , and PBL , whereas marginal levels of the transcripts were detected in other tissues ,'}]}, {'start':(15, 73), 'end':(15, 99), 'text':'including prostate , testis , ovary , colon , heart , brain , placenta , lung , liver , skeletal muscle , kidney , and pancreas .'}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 2), 'text':'These results suggest'}, {'start':(16, 3), 'end':(16, 21), 'text':'that Grf40 , unlike Grb2 , is predominantly expressed in immunotissues and hematopoietic cells , particularly T cells .'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 11), 'text':'Since Grb2 has been shown to bind to SLP-76 and LAT ,'}, {'start':(17, 12), 'end':(17, 16), 'text':'which are 76- and 36'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 17), 'end':(17, 32), 'text':'and 38-kD tyrosine phosphorylated proteins essential for TCR mediated signaling , respectively , we asked ourselves'}, {'start':(17, 33), 'end':(17, 44), 'text':'whether or not Grf40 is also associated with SLP-76 and LAT .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 9), 'text':'We detected 76- and 36 and 38-kD tyrosine phosphorylated proteins'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 10), 'end':(18, 21), 'text':'that coimmunoprecipitated with Grf40 in Jurkat cells after stimulation by TCR cross'}, {'start':(18, 22), 'end':(18, 25), 'text':'linking with OKT3 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 2), 'text':'We then confirmed'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(19, 3), 'end':(19, 19), 'text':'that the 76- and 36 and 38-kD tyrosine phosphorylated proteins were SLP-76 and LAT , respectively ,'}, {'start':(19, 20), 'end':(19, 26), 'text':'by stimulating Jurkat cells with OKT3 .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 0), 'end':(20, 7), 'text':'Their lysates were immunoprecipitated with anti-Grf40 Ab ,'}, {'start':(20, 8), 'end':(20, 22), 'text':'and the immunoprecipitates were then immunoblotted with anti-LAT , anti-SLP-76 , or anti-Grf40 Ab .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 7), 'text':'Grf40 precipitated SLP-76 irrespective of TCR stimulation ,'}, {'start':(21, 8), 'end':(21, 15), 'text':'but precipitated LAT only after TCR stimulation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 14), 'text':'These results indicate the association of Grf40 with SLP-76 and LAT in Jurkat cells .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 9), 'text':'To determine the association site of Grf40 for SLP-76 ,'}, {'start':(23, 10), 'end':(23, 25), 'text':'we carried out further coimmunoprecipitation assays between the various deletion mutants of Grf40 and SLP-76 .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 13), 'text':'COS7 cells were transiently transfected with Myc tagged wild-type Grf40 and four Grf40 mutants'}, {'start':(24, 14), 'end':(24, 25), 'text':'deleted of the NH 2 -terminal SH3 domain ( Grf40-dSH3N ) ,'}]}, {'start':(24, 26), 'end':(24, 54), 'text':'the COOH-terminal SH3 domain ( Grf40-dSH3C ) , both the NH 2 - and COOH-terminal SH3 domains ( Grf40-dSH3NC ) , or the SH2 domain ( Grf40-dSH2 ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(25, 0), 'end':(25, 12), 'text':'The transfected COS7 cells were immunoprecipitated with anti-SLP-76 Ab or anti-Myc mAb ,'}, {'start':(25, 13), 'end':(25, 22), 'text':'and then immunoblotted with anti-Myc mAb or anti-SLP-76 Ab .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(26, 0), 'end':(26, 13), 'text':'Wild-type Grf40 and the Grf40-dSH2 and Grf40 dSH3N mutants were coimmunoprecipitated with SLP-76 ,'}, {'start':(26, 14), 'end':(26, 24), 'text':'but the Grf40-dSH3C and Grf40 dSH3NC mutants were not tested .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 21), 'text':'Conversely , SLP-76 was coimmunoprecipitated with Grf40-dSH2 , Grf40-dSH3N , and wild-type Grf40 , but not with Grf40-dSH3C and Grf40 dSH3NC mutants'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 22), 'end':(27, 23), 'text':'( data'}, {'start':(27, 24), 'end':(27, 27), 'text':'not shown ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 2), 'text':'These results indicate'}, {'start':(28, 3), 'end':(28, 16), 'text':'that the COOH-terminal SH3 domain of Grf40 is an association site for SLP-76 .'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 9), 'text':'We next determined the association site of SLP-76 for Grf40'}, {'start':(29, 10), 'end':(29, 16), 'text':'by using various SLP 76 mutants .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 15), 'text':'Flag tagged wild-type and four mutants of SLP-76 were introduced into COS7 cells together with Myc'}, {'start':(30, 16), 'end':(30, 18), 'text':'tagged Grf40 ,'}]}, {'start':(30, 19), 'end':(30, 29), 'text':'and then immunoprecipitated and immunoblotted with anti-Flag and anti-Myc Abs .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 9), 'text':'Myc tagged Grf40 was coimmunoprecipitated with the SLP 76 mutants'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 10), 'end':(31, 29), 'text':'consisting of and containing the amino acid position Glu 217 -Pro 533 , but not with the SLP 76 mutant'}, {'start':(31, 30), 'end':(31, 40), 'text':'consisting of the amino acid position Pro 241 -Pro 533 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 2), 'text':'These results indicate'}, {'start':(32, 3), 'end':(32, 21), 'text':'that the Grf40 binding site is located in the amino acid position Glu 217 -Lys 240 of SLP-76 .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 16), 'text':'This Grf40 binding site of SLP-76 almost overlaps the amino acid position Asn 224 -Asp 244 ,'}, {'start':(33, 17), 'end':(33, 29), 'text':'which has been shown to be the Grb2 binding site ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 22), 'text':'On the other hand , the binding site of Grb2 for LAT has been shown to be the SH2 domain of Grb2 ,'}, {'start':(34, 23), 'end':(34, 35), 'text':'which is thought to bind to the phosphorylated tyrosine residue ( ) .'}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 6), 'text':'Together with this notion , we showed'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(35, 7), 'end':(35, 20), 'text':'that LAT is tyrosine phosphorylated and subsequently coimmunoprecipitated with Grf40 after TCR stimulation ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(35, 21), 'end':(35, 21), 'text':'suggesting'}, {'start':(35, 22), 'end':(35, 35), 'text':'that the SH2 domain of Grf40 is possibly the binding site for LAT .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 17), 'text':'Since the COOH-terminal SH3 domain of Grb2 has been shown to be the binding site for SLP-76 ,'}, {'start':(36, 18), 'end':(36, 30), 'text':'we examined the competitive binding ability between Grf40 and Grb2 to SLP-76 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(37, 0), 'end':(37, 14), 'text':'COS7 cells were transiently transfected with 2.5-mug plasmids of Myc tagged Grf40 and Myc tagged'}, {'start':(37, 15), 'end':(37, 31), 'text':'Grb2 in association with different doses ( 0-1 .0 mug ) of Flag tagged SLP-76 plasmid .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(38, 0), 'end':(38, 6), 'text':'Their lysates were immunoprecipitated with anti-Flag mAb'}, {'start':(38, 7), 'end':(38, 14), 'text':'and then immunoblotted with anti-Myc polyclonal Ab .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 6), 'text':'Coimmunoprecipitation of Myc tagged Grf40 with SLP-76'}, {'start':(39, 7), 'end':(39, 18), 'text':'gradually decreased upon reducing the SLP-76 plasmid dose to 0.05 mug ,'}]}, {'start':(39, 19), 'end':(39, 37), 'text':'whereas the Myc tagged Grb2 coimmunoprecipitation with SLP-76 was detectable only at a 1.0-mug dose of SLP-76 plasmid .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 10), 'text':'Expression levels of the plasmids introduced were quantified by immunoblotting ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(40, 11), 'end':(40, 11), 'text':'confirming'}, {'start':(40, 12), 'end':(40, 29), 'text':'that there was no significant difference in the amounts between Myc tagged Grf40 and Myc tagged Grb2 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 4), 'text':'These results suggest the possibility'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 5), 'end':(41, 6), 'text':'that Grf40'}, {'start':(41, 7), 'end':(41, 15), 'text':'associated much stronger with SLP-76 than did Grb2 .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(42, 0), 'end':(42, 4), 'text':'To confirm this further ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(42, 5), 'end':(42, 26), 'text':'COS7 cells were transiently transfected with low doses of SLP-76 plasmid ( 0.2 mug ) and Myc-Grf40 plasmid ( 2.5 mug )'}, {'start':(42, 27), 'end':(42, 40), 'text':'together with various doses ( 0-10 mug ) of Myc tagged Grb2 plasmid .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(43, 0), 'end':(43, 6), 'text':'Their lysates were immunoprecipitated with anti-Flag mAb'}, {'start':(43, 7), 'end':(43, 14), 'text':'and then immunoblotted with anti-Myc polyclonal Ab .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'temporal', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 13), 'text':'Even when up to 10-mug plasmid doses of Myc tagged Grb2 were cotransfected ,'}, {'start':(44, 14), 'end':(44, 24), 'text':'coimmunoprecipitation of Myc tagged Grf40 with SLP-76 was still unchanged .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(45, 0), 'end':(45, 1), 'text':'Furthermore ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 2), 'end':(45, 16), 'text':'although the increased expression of Myc tagged Grb2 was dependent on its plasmid dose ,'}, {'start':(45, 17), 'end':(45, 20), 'text':'which was considerably higher'}]}, {'start':(45, 21), 'end':(45, 34), 'text':'than that of Grf40 at a 10-mug plasmid dose of Myc tagged Grb2 ,'}]}, {'start':(45, 35), 'end':(45, 43), 'text':'Myc tagged Grb2 was not coimmunoprecipitated with SLP-76 .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 0), 'end':(46, 2), 'text':'These results indicate'}, {'start':(46, 3), 'end':(46, 13), 'text':'that Grf40 competes with Grb2 in its binding to SLP-76 ,'}]}, {'start':(46, 14), 'end':(46, 29), 'text':'and the binding affinity of Grf40 to SLP-76 is apparently higher than that of Grb2 .'}]}]}]}]}]}]}, {'label':'topic-comment', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 4), 'text':'Since the SLP 76 mutant'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 5), 'end':(47, 11), 'text':'deleted of the Grb2 binding site ,'}, {'start':(47, 12), 'end':(47, 18), 'text':'which overlaps the Grf40 binding site ,'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(47, 19), 'end':(47, 28), 'text':'failed to increase IL-2 promoter activity upon TCR stimulation ,'}, {'start':(47, 29), 'end':(47, 51), 'text':'it is possible that not only Grb2 but also Grf40 plays a critical role in the SLP-76-dependent increase in IL-2 promoter activity .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 11), 'text':'To address the functional significance of Grf40 in TCR mediated signaling ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 12), 'end':(48, 18), 'text':'we performed luciferase assays with reporter genes'}, {'start':(48, 19), 'end':(48, 28), 'text':'containing the IL-2 promoter and the NF-AT binding domain .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 21), 'text':'Overexpression of wild-type Grf40 did not lead to either basal or TCR mediated activation of the IL-2 promoter and NF-AT ( data'}, {'start':(49, 22), 'end':(49, 25), 'text':'not shown ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(50, 0), 'end':(50, 8), 'text':'Since Grf40 interacts with SLP-76 in Jurkat cells ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(50, 9), 'end':(50, 27), 'text':'and overexpression of SLP-76 is known to augment TCR mediated stimulation of the IL-2 promoter and NF-AT activity ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 28), 'end':(50, 31), 'text':'we used Jurkat cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 32), 'end':(50, 35), 'text':'transiently transfected with SLP-76'}, {'start':(50, 36), 'end':(50, 46), 'text':'to examine the effect of Grf40 in TCR mediated signaling .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 10), 'text':'Transfections of wild-type Grf40 and Grf40 dSH3N mutant into Jurkat cells'}, {'start':(51, 11), 'end':(51, 12), 'text':'overexpressing SLP-76'}]}, {'start':(51, 13), 'end':(51, 27), 'text':'led to significant increases in IL-2 promoter activity upon stimulation with OKT3 plus PMA ,'}]}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(51, 28), 'end':(51, 41), 'text':'whereas transfection of Grf40 dSH2 mutant induced a marked inhibition of IL-2 promoter activity'}, {'start':(51, 42), 'end':(51, 49), 'text':'compared with transfection of an empty vector .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(52, 0), 'end':(52, 2), 'text':'These results indicate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 3), 'end':(52, 15), 'text':'that Grf40 dSH2 mutant has a dominant negative effect in TCR stimulation ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(52, 16), 'end':(52, 16), 'text':'suggesting'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 17), 'end':(52, 32), 'text':'that the SH2 domain of Grf40 interacts with an essential molecule for TCR mediated signaling ,'}, {'start':(52, 33), 'end':(52, 39), 'text':'which is possibly LAT ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 10), 'text':'Similar results were obtained in NF-AT luciferase assays with Jurkat cells'}, {'start':(53, 11), 'end':(53, 14), 'text':'stimulated with OKT3 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 9), 'text':'Furthermore , the Grf40 mutants ( Grf40-dSH3C and Grf40-dSH3NC )'}, {'start':(54, 10), 'end':(54, 16), 'text':'deleted of the COOH-terminal SH3 domain ,'}]}, {'start':(54, 17), 'end':(54, 24), 'text':'which is the binding site for SLP-76 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 25), 'end':(54, 28), 'text':'also lost their ability'}, {'start':(54, 29), 'end':(54, 34), 'text':'to increase IL-2 promoter activity ,'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(54, 35), 'end':(54, 35), 'text':'suggesting'}, {'start':(54, 36), 'end':(54, 47), 'text':'that a Grf40-SLP-76 complex formation is required for SLP-76-dependent TCR stimulation .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(55, 0), 'end':(55, 2), 'text':'These results indicate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 3), 'end':(55, 17), 'text':'that Grf40 is involved in signaling the stimulation of the IL-2 promoter and NF-AT activities'}, {'start':(55, 18), 'end':(55, 23), 'text':'mediated by OKT3 and PMA .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(56, 0), 'end':(56, 19), 'text':'Since Grb2 has also been considered to be involved in the modulation of TCR mediated signal transduction ( ) ,'}, {'start':(56, 20), 'end':(56, 37), 'text':'we compared the functional significance of Grf40 and Grb2 in TCR mediated stimulation of IL-2 promoter activity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 0), 'end':(57, 1), 'text':'Jurkat cells'}, {'start':(57, 2), 'end':(57, 3), 'text':'overexpressing SLP-76'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 4), 'end':(57, 23), 'text':'were transfected with the wild-types and SH2 deletion mutants of Grf40 and Grb2 , in association with an IL-2 promoter'}, {'start':(57, 24), 'end':(57, 27), 'text':'driven luciferase construct .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(58, 0), 'end':(58, 7), 'text':'They were stimulated with OKT3 plus PMA ,'}, {'start':(58, 8), 'end':(58, 13), 'text':'and assayed for luciferase activity .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 18), 'text':'An appreciable enhancement of IL-2 promoter activity was seen with wild-type Grf40 , but scarcely with wild-type Grb2 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 19), 'end':(59, 33), 'text':'whereas Grf40 dSH2 mutant showed a marked dominant negative effect in the IL-2 luciferase assay'}, {'start':(59, 34), 'end':(59, 39), 'text':'compared with Grb2 dSH2 mutant .'}]}]}, {'start':(60, 0), 'end':(60, 18), 'text':'The plasmid dose dependency in the IL-2 luciferase assay was compared between the Grf40-dSH2 and Grb2 dSH2 mutants .'}]}]}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 22), 'text':'The suppressive effects on the luciferase activities were significantly stronger in Grf40 dSH2 mutant than Grb2 dSH2 mutant at various plasmid doses .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(62, 0), 'end':(62, 2), 'text':'These results indicate'}, {'start':(62, 3), 'end':(62, 15), 'text':'that Grf40 is involved in TCR mediated signaling more effectively than Grb2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 15), 'text':'This conclusion is in accordance with the observation of greater binding affinity of Grf40 to SLP-76'}, {'start':(63, 16), 'end':(63, 19), 'text':'compared with Grb2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 0), 'end':(64, 11), 'text':'This study showed a critical involvement of Grf40 in the SLP-76-dependent signaling'}, {'start':(64, 12), 'end':(64, 16), 'text':'mediated by the TCR .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 0), 'end':(65, 4), 'text':'One might consider the possibility'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(65, 5), 'end':(65, 14), 'text':'that Grf40 mutants exert their effects in TCR mediated signaling'}, {'start':(65, 15), 'end':(65, 21), 'text':'by altering expression levels of SLP-76 .'}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(66, 0), 'end':(66, 5), 'text':'However , this possibility is negligible'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 6), 'end':(66, 31), 'text':'because the expression of pCX-SLP76 was confirmed to be unaffected by transient expression of Grf40 , Grb2 , and their mutants in COS7 cells ( data'}, {'start':(66, 32), 'end':(66, 35), 'text':'not shown ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 0), 'end':(67, 19), 'text':'Hence , the interaction of Grf40 with SLP-76 and LAT is thought to be critical for TCR mediated signaling .'}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 0), 'end':(68, 24), 'text':'The NH 2 -terminal SH3 domain of Grb2 is known to be a binding site for Sos , a Ras guanine nucleotide exchange factor ,'}, {'start':(68, 25), 'end':(68, 40), 'text':'which has been considered to be involved in Ras activation upon TCR stimulation ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 25), 'text':'We confirmed the association of Grb2 with Sos in Jurkat cells ; however , a complex formation between Grf40 and Sos was undetectable in these cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 26), 'end':(69, 27), 'text':'( data'}, {'start':(69, 28), 'end':(69, 31), 'text':'not shown ) .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(70, 0), 'end':(70, 3), 'text':'Therefore , we suspect'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 4), 'end':(70, 12), 'text':'that Grf40 does not direct the Ras activation signaling'}, {'start':(70, 13), 'end':(70, 17), 'text':'mediated by the TCR .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 18), 'text':'However , Grf40 contributes to TCR mediated activation of the IL-2 promoter and NF-AT more effectively than Grb2 ,'}, {'start':(71, 19), 'end':(71, 29), 'text':'suggesting the critical involvement of Grf40 in TCR mediated signaling .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(72, 0), 'end':(72, 3), 'text':'In this context ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 4), 'end':(72, 7), 'text':'it is of interest'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 8), 'end':(72, 9), 'text':'that SLP-76'}, {'start':(72, 10), 'end':(72, 26), 'text':'associated with Grf40 also binds to Vav , a Rac and Rho guanine nucleotide exchange factor ,'}]}, {'start':(72, 27), 'end':(72, 49), 'text':'and that the interaction between SLP-76 and Vav has been shown to participate in IL-2 gene activation upon TCR stimulation ( ) .'}]}]}]}]}]}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 0), 'end':(73, 5), 'text':'These observations provide a model pathway'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 6), 'end':(73, 11), 'text':'in which activated ZAP-70 tyrosine kinase'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 12), 'end':(73, 16), 'text':'after TCR ligation phosphorylates LAT'}, {'start':(73, 17), 'end':(73, 19), 'text':'( ) ,'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(73, 20), 'end':(73, 27), 'text':'which then binds to the preformed Grf40-SLP-76 complex'}, {'start':(73, 28), 'end':(73, 35), 'text':'and recruits it to ZAP-70 ( ) ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 36), 'end':(73, 39), 'text':'which further phosphorylates SLP-76'}, {'start':(73, 40), 'end':(73, 45), 'text':'to be associated with Vav ,'}]}]}, {'start':(73, 46), 'end':(73, 54), 'text':'leading to the downstream signaling of the TCR .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(74, 0), 'end':(74, 5), 'text':'Northern blot and immunoblot analyses revealed'}, {'start':(74, 6), 'end':(74, 25), 'text':'that Grf40 is expressed predominantly in immunotissues and hematopoietic cells , particularly T cells , in contrast to Grb2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(75, 0), 'end':(75, 16), 'text':'Such restricted distribution of Grf40 may reflect the more efficient involvement of Grf40 in TCR mediated signaling'}, {'start':(75, 17), 'end':(75, 20), 'text':'compared with Grb2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(76, 0), 'end':(76, 16), 'text':'Although Grap has also been shown to be specific for hematopoietic and lymphocytic cells ( ) ,'}, {'start':(76, 17), 'end':(76, 25), 'text':'the functional significance of Grap is still unknown .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 14), 'text':'The genome sequence of GRB2L has been registered in GenBank/EMBL/DDBJ ( under accession no .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(78, 0), 'end':(78, 2), 'text':'Z82206 ) ,'}, {'start':(78, 3), 'end':(78, 10), 'text':'which contains the entire sequence of Grf40 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(79, 0), 'end':(79, 9), 'text':'Since GRB2L has been mapped to human chromosome 22q12 ,'}, {'start':(79, 10), 'end':(79, 19), 'text':'Grf40 is thought to have the same chromosomal location .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(80, 0), 'end':(80, 18), 'text':'Furthermore , cDNA clones identical to Grf40 were reported as Grap2 ( ) , and human Gads ( )'}, {'start':(80, 19), 'end':(80, 23), 'text':'and their mouse homologues ,'}]}, {'start':(80, 24), 'end':(80, 33), 'text':'named Mona ( ) and mouse Gads ( ) ,'}]}, {'start':(80, 34), 'end':(80, 43), 'text':'were also reported after the submission of this paper .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(81, 0), 'end':(81, 12), 'text':'Although the report regarding human Gads showed similar results as our study ,'}, {'start':(81, 13), 'end':(81, 24), 'text':'they did not show any comparative study between Gads and Grb2 .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(82, 0), 'end':(82, 2), 'text':'We here show'}, {'start':(82, 3), 'end':(82, 3), 'text':'evidence'}]}, {'start':(82, 4), 'end':(82, 4), 'text':'suggesting'}]}, {'start':(82, 5), 'end':(82, 19), 'text':'that Grf40 plays a more critical role in the TCR mediated signaling than Grb2 .'}]}]}
